Joachim Kalden
Overview
Explore the profile of Joachim Kalden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
1513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winthrop K, Weinblatt M, Bathon J, Burmester G, Mease P, Crofford L, et al.
Ann Rheum Dis
. 2019 Oct;
79(1):88-93.
PMID: 31662322
Objectives: To detail the greatest areas of unmet scientific and clinical needs in rheumatology. Methods: The 21st annual international Advances in Targeted Therapies meeting brought together more than 100 leading...
2.
Winthrop K, Weinblatt M, Crow M, Burmester G, Mease P, So A, et al.
Ann Rheum Dis
. 2019 Feb;
78(7):872-878.
PMID: 30712015
To develop a comprehensive listing of the greatest unmet scientific and clinical needs in rheumatology. The 20th annual international Targeted Therapies meeting brought more than 100 leading basic scientists and...
3.
Cauli A, Gladman D, Mathieu A, Olivieri I, Porru G, Tak P, et al.
J Rheumatol
. 2018 Jun;
45(9):1256-1262.
PMID: 29907666
Objective: Physician's global assessment (PGA) of disease activity is a major determinant of therapeutic decision making. This study assesses the reliability of the PGA, measured by means of 0-100 mm...
4.
Winthrop K, Strand V, van der Heijde D, Mease P, Crow M, Weinblatt M, et al.
Clin Immunol
. 2017 Aug;
186:87-93.
PMID: 28811201
The 19th annual international Targeted Therapies meeting brought together over 100 leading basic scientists and clinical researchers from around the world in the field of immunology, molecular biology and rheumatology...
5.
Furst D, Fleischman R, Kalden J, Kavanaugh A, Sieper J, Mease P, et al.
Ann Rheum Dis
. 2013 Mar;
72 Suppl 2:ii35-51.
PMID: 23532442
No abstract available.
6.
Haraoui B, Smolen J, Aletaha D, Breedveld F, Burmester G, Codreanu C, et al.
Ann Rheum Dis
. 2011 Aug;
70(11):1999-2002.
PMID: 21803747
Aim: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. Methods: A 10-point Likert scale...
7.
Schoels M, Knevel R, Aletaha D, Bijlsma J, Breedveld F, Boumpas D, et al.
Ann Rheum Dis
. 2010 Mar;
69(4):638-643.
PMID: 20237123
Objectives: To summarise existing evidence on a target oriented approach for rheumatoid arthritis (RA) treatment. Methods: We conducted a systematic literature search including all clinical trials testing clinical, functional, or...
8.
Smolen J, Aletaha D, Bijlsma J, Breedveld F, Boumpas D, Burmester G, et al.
Ann Rheum Dis
. 2010 Mar;
69(4):631-7.
PMID: 20215140
Background: Aiming at therapeutic targets has reduced the risk of organ failure in many diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid arthritis (RA)....
9.
Schoels M, Aletaha D, Smolen J, Bijlsma J, Burmester G, Breedveld F, et al.
Ann Rheum Dis
. 2009 Apr;
69(3):575-8.
PMID: 19389716
Background: Therapeutic approaches to rheumatoid arthritis (RA) have undergone significant changes. The importance of tight control and early treatment, rapidly altered if goals are not achieved, is supported by evidence....
10.
Gaipl U, Munoz L, Grossmayer G, Lauber K, Franz S, Sarter K, et al.
J Autoimmun
. 2007 Mar;
28(2-3):114-21.
PMID: 17368845
Systemic lupus erythematosus (SLE) is a fairly heterogeneous autoimmune disease. Impaired clearance functions for dying cells may explain accumulation of nuclear autoantigens in various tissues of SLE patients. Our data...